Valued at USD 6.26 billion in 2024, the global medical filtration market is projected to reach USD 6.67 billion in 2025 and USD 11.93 billion by 2034, growing at a CAGR of 6.7% during the forecast period 2025–2034. Demand is shaped by the growing incidence of chronic diseases, rising drug development activity, healthcare investment in emerging nations and advances in filtration technology. Key players include Baxter, Donaldson Company Inc., Entegris, MANN+HUMMEL, Parker Hannifin Corp. and Veolia.

Chronic Diseases Drive Medical Filtration Demand

According to the World Health Organization, noncommunicable diseases, also known as chronic diseases, killed at least 43 million people in 2021. Chronic diseases such as diabetes, cardiovascular disease and kidney failure require ongoing treatment, increasing the need for procedures such as dialysis and surgery, which depend on medical filters to ensure the sterility and safety of equipment and fluids. Respiratory diseases, including COPD and asthma, also drive demand, because patients are highly susceptible to airborne contaminants, allergens and pathogens. Hospitals therefore install high-efficiency particulate air filters to maintain clean air in critical care units, operating rooms and patient wards. The Centers for Disease Control and Prevention estimates that 129 million people in the US have at least one major chronic disease.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/medical-filtration-market

Dialysis and Application Coverage

By application, the report covers dialysis, drug delivery, IV infusion & sterile filtration, endoscopy, sterile processing, bio-artificial processes and others. The rising prevalence of chronic kidney disease and increasing demand for dialysis treatments have contributed to the dominance of the leading material segment. By end user, the market is segmented into hospitals, diagnostic centers and research institutes, and hospitals and dialysis centers rely on advanced membrane technologies for blood purification and critical care treatments.

Drug Development and Monoclonal Antibodies

Growing drug development activity is a major growth driver. Developing new drugs involves rigorous testing and manufacturing that demand high levels of sterility and purity, and regulators impose strict guidelines to ensure patient safety. Filtration helps pharmaceutical companies comply by removing contaminants. The rise of biopharmaceuticals such as vaccines and monoclonal antibodies further lifts demand, because these complex biological drugs require sophisticated filtration processes to maintain efficacy and safety, and their production often involves multiple filtration steps.

Healthcare Investment in Emerging Nations

Increased healthcare investment in emerging economies is improving infrastructure, including new hospitals and clinics that require advanced equipment and filtration systems. The share of Government Health Expenditure in India's GDP rose from 1.13% in 2014–15 to 1.84% in 2021–22. Emerging nations also face higher rates of infectious diseases and limited access to clean water, and rising medical tourism in India, Thailand, Brazil and Mexico boosts demand for clean surgical environments and sterile operating rooms.

Regional Outlook

North America dominated in 2024, with the US benefiting from major pharmaceutical companies, government funding and strict FDA regulations mandating high-quality filtration systems. Emphasis on infection control, particularly hospital-acquired infections and pandemic preparedness, has widened adoption. Asia Pacific is estimated to grow at a rapid pace as China, India and Japan invest in biotechnology, biopharmaceuticals and medical device manufacturing, with China expected to dominate the regional market. Expanding government healthcare programs and rising medical tourism in India and Thailand have accelerated the need for high-efficiency filtration technologies in hospitals and surgical centers, while rising infectious disease incidence and growing demand for vaccines and biologics are estimated to fuel adoption. In North America, a rising number of surgical procedures has further fueled the need for superior contamination control.

Competitive Insights

The medical filtration market is fragmented, with participants including Asahi Kasei Corporation, Baxter, Danaher, Donaldson Company Inc., Entegris, MANN+HUMMEL, Merck KGaA, Parker Hannifin Corp., Sartorius AG, Thermo Fisher Scientific Inc. and Veolia. In December 2025, Camfil acquired F.C.R., an Italian air filtration solutions company, enhancing its footprint in Italy. High costs of advanced filtration technologies and limited budgets in emerging markets could restrict growth.

More Trending Latest Reports By Polaris Market Research:

quick-service-restaurants-qsr-market

data-center-switch-market

exosomes-market

nonlinear-optical-crystals-market

aerogel-market

dupixent-market

fire-resistant-fabrics-market

us-c4isr-market

fuel-additives-market